Update on Advanced Anti-CD20 Therapeutics to Improve Outcomes for Patients with Multiple Sclerosis - AcademicCME

Update on Advanced Anti-CD20 Therapeutics to Improve Outcomes for Patients with Multiple Sclerosis

1.0

Claim your AMA PRA Category 1 Credit

Already have an Account? Log In
Don’t have an account? Register Today

Claim your Certificate

course Faculty

No data was found

Related Courses

The New Era of Biologic Therapies to Treat Patients with COPD: Best Practices for the Pulm...

Management of Patients with Non-Cystic Fibrosis Bronchiectasis: Reducing Burden of Disease...

Clinical Update on the Evolving Role of B-Cell Targeting Therapies to Improve Outcomes in ...